Search results for " Choline"

showing 6 items of 56 documents

Immunochemical characterization of anti-acetylcholine receptor antibodies in primary biliary cirrhosis

1988

Although the presence of anti-mitochondrial antibodies is the main characteristic of primary biliary cirrhosis (PBC), other autoantibodies have been described in this disease. This study employs immunoblot methods to test whether the sera of PBC patients also contain antibodies directed against nicotinic acetylcholine receptors (AChR). We show that the majority of patients' sera indeed react with AChR just as sera of myasthenic patients do. In contrast, however, these anti-AChR antibodies do not lead to significant clinical symptoms of myasthenia. In all cases studied, PBC sera recognized a protein with the molecular weight of the alpha-chain of acetylcholine receptor (40 kDa). In addition,…

medicine.medical_specialtyHepatologyLiver Cirrhosis BiliaryAutoantibodyBiologymedicine.diseaseImmunohistochemistryPrimary biliary cirrhosisNicotinic agonistEndocrinologyAntigenInternal medicinemedicinebiology.proteinHumansImmunohistochemistryElectrophoresis Polyacrylamide GelReceptors CholinergicIsoelectric PointAntibodyReceptorImmunosorbent TechniquesAutoantibodiesAcetylcholine receptorJournal of Hepatology
researchProduct

Presence of muscarinic inhibitory and absence of nicotinic excitatory receptors at the terminal sympathetic nerves of chicken hearts.

1976

Nicotine (2 X 10(-4) M) or acetylcholine (5.5 X 10(-4) M) in the presence of 3 X 10(-6) M atropine did not increase the rate or amplitude of contraction in isolated atria or ventricular strips of the chicken heart; both drugs also did not cause an output of noradrenaline or adrenaline and did not evoke antidromic discharges in the right sympathetic nerves of isolated perfused chicken hearts. In contrast, "high K+-solutions" evoked an output of noradrenaline and adrenaline and caused a burst of antidromic discharges. Dimethylphenylpiperazine (DMPP; 3.1 X 10(-4) M), by a tyramine-like action, elicited a small output of noradrenaline and increased rate and amplitude of contraction" but did not…

medicine.medical_specialtyNicotineSympathetic Nervous SystemEpinephrineTyramineStimulationIn Vitro TechniquesReceptors NicotinicInhibitory postsynaptic potentialNorepinephrineHeart RateInternal medicineMuscarinic acetylcholine receptormedicineAnimalsReceptors CholinergicEvoked PotentialsPharmacologyChemistryMyocardiumHeartGeneral MedicineMyocardial ContractionReceptors MuscarinicAcetylcholineAntidromicAtropineNicotinic agonistEndocrinologyExcitatory postsynaptic potentialCatsPotassiumDimethylphenylpiperazinium IodideChickensAcetylcholinemedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

The non-neuronal cholinergic system in humans: expression, function and pathophysiology.

2003

Acetylcholine, a prime example of a neurotransmitter, has been detected in bacteria, algae, protozoa, and primitive plants, indicating an extremely early appearance in the evolutionary process (about 3 billion years). In humans, acetylcholine and/or the synthesizing enzyme, choline acetyltransferase (ChAT), have been found in epithelial cells (airways, alimentary tract, urogenital tract, epidermis), mesothelial (pleura, pericardium), endothelial, muscle and immune cells (mononuclear cells, granulocytes, alveolar macrophages, mast cells). The widespread expression of non-neuronal acetylcholine is accompanied by the ubiquitous presence of cholinesterase and receptors (nicotinic, muscarinic). …

medicine.medical_specialtyPlacentaBiologyGeneral Biochemistry Genetics and Molecular BiologyCholine O-AcetyltransferasePregnancyInternal medicineMuscarinic acetylcholine receptorMuscarinic acetylcholine receptor M5medicineMuscarinic acetylcholine receptor M4AnimalsHumansReceptors CholinergicGeneral Pharmacology Toxicology and PharmaceuticsInflammationMuscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M2General MedicineAcetylcholineCell biologyEndocrinologyNicotinic agonistCholinergicFemaleAcetylcholinemedicine.drugSubcellular FractionsLife sciences
researchProduct

Do adrenergic fibres have muscarinic inhibitory receptors?-- a reply.

1974

medicine.medical_specialtySympathetic Nervous SystemPharmaceutical ScienceAdrenergicIn Vitro TechniquesDogsInternal medicineMuscarinic acetylcholine receptormedicineAnimalsReceptors CholinergicSaphenous VeinPharmacologyNeuronsChemistryInhibitory receptorsHeartAcetylcholineElectric StimulationStimulation ChemicalMesenteric ArteriesRatsPerfusionEndocrinologyCatsRabbitsSpleenThe Journal of pharmacy and pharmacology
researchProduct

The pharmacological rationale for combining muscarinic receptor antagonists and beta-adrenoceptor agonists in the treatment of airway and bladder dis…

2014

Highlights • Muscarinic receptors increase smooth muscle tone in airways and urinary bladder. • β-Adrenoceptors relax smooth muscle tone and oppose muscarinic contraction. • Opposition involves transmitter release, signal transduction and receptor expression. • This supports the combined use of muscarinic antagonists and β-adrenoceptor agonists.

medicine.medical_specialtyUrologyDiseaseMuscarinic AntagonistsPharmacologyArticleβ adrenoceptorchemistry.chemical_compoundInternal medicineReceptors Adrenergic betaMuscarinic acetylcholine receptorDrug DiscoveryMuscarinic acetylcholine receptor M4RAT URINARY-BLADDERMedicineAnimalsHumansCyclic adenosine monophosphateADRENERGIC RELAXATIONLung Diseases ObstructivePROTEIN-KINASE-CReceptorTRACHEAL SMOOTH-MUSCLEPharmacologybusiness.industryUrinary Bladder DiseasesMuscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M2ACETYLCHOLINE-RELEASEAdrenergic beta-Agonistsmedicine.diseaseReceptors MuscarinicEndocrinologyNONNEURONAL CHOLINERGIC SYSTEMchemistryGUINEA-PIG TRACHEADrug Therapy CombinationCYCLIC ADENOSINE-MONOPHOSPHATECA2+-ACTIVATED K+ CHANNELAirwaybusinessUrinary bladder diseaseAUTORADIOGRAPHIC VISUALIZATIONAcetylcholinemedicine.drug
researchProduct

Kinetic evidence for the incorporation of the [(pentamethylcyclopentadienyl) (2,2′-bipyridyl)(aquo)rhodium(III)] complex into DPPC vesicles

2008

Abstract The binding of the [(pentamethylcyclopentadienyl) (2,2′-bipyridyl)(aquo)rhodium(III)] complex [Cp*RhIII(bpy)H2O]2+, to l -α-dipalmitoylphosphatidyl choline (DPPC) vesicles has been estimated by studying the kinetics of the electron transfer reaction between the rhodium(III) complex and formiate ions. Kinetic measurements carried out under anaerobic conditions in absence and presence of DPPC show that the total reaction is composed of two steps. The rate of the first reaction increases with the phospholipid concentration, while that of the second process is independent of the concentration of DPPC. This is consistent with a reaction, where the two reacting species are partitioned be…

vesicles L-alfa-dipalmitoylphosphatidyl choline (DPPC) rate constant bindingAqueous solutionLiaisonStereochemistryVesicleKineticstechnology industry and agriculturePhospholipidchemistry.chemical_elementBinding constantRhodiumchemistry.chemical_compoundCrystallographyElectron transferColloid and Surface Chemistrychemistrylipids (amino acids peptides and proteins)Colloids and Surfaces A: Physicochemical and Engineering Aspects
researchProduct